Key result
Post-PCI CK-MB elevation, but not troponin, is linked to ~90% higher 2-year mortality.
Why the study?
The long-term mortality risk of mild post-PCI CK-MB elevations remains controversial, and the prognostic significance of post-procedural cardiac troponin elevations has not been established.
Does post-procedural elevation of CK-MB or cTnI predict 2-year mortality in patients undergoing PCI?
Cohort (n=3,494)
Yes
Does post-procedural elevation of CK-MB or cTnI predict 2-year mortality in patients undergoing PCI?
Post-procedural elevation of CK-MB, but not cTnI, is an independent predictor of 2-year mortality following PCI.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“This large cohort follow-up study is of particular relevance for the interventional cardiologist, as it gives further data about the impact of procedure-induced myonecrosis on long-term outcome following PCI.”
“Although we agree that calculating the peak ratio in the case of high baseline levels is arbitrary and may lead to an underestimate of the degree of elevation, we consider it a reasonable attempt to separate the amount of myocardial damage due to the interventional procedure per se from that attributed to pre-procedural myocardial necrosis.”
Post-PCI CK-MB elevations may signal higher long-term mortality; leaves open independent prognostic value of troponin elevations.
AIMS: Retrospective studies and post hoc analyses have suggested that mild elevations in the creatine kinase-MB (CK-MB) isoenzyme following percutaneous coronary intervention (PCI) may be associated with an increased risk of death in the long term. However, this finding is still controversial, and the prognostic significance of elevations of more sensitive markers of myocardial damage, such as the cardiac troponins, has not been established. In this multicentre prospective cohort study, we evaluated the influence of post-procedural elevations of CK-MB and troponin I (cTnI) on long-term mortality. METHODS AND RESULTS: The CK-MB and PCI study included 3494 consecutive patients undergoing PCI from February 2000 to October 2000 in 16 Italian tertiary centres. Blood samples were collected at baseline, and at 8-12 and 18-24 h after the procedure, and were analysed in a core biochemistry laboratory. CK-MB elevation was detected in 16% of the patients, and was associated with increased 2-year mortality [7.2 vs. 3.8%; odds ratio (OR): 1.9; 95% confidence interval (CI): 1.3-2.8; P<0.001). The degree of CK-MB elevation (peak CK-MB ratio) independently predicted the risk of death (adjusted OR per unit: 1.04; 95% CI: 1.01-1.07; P=0.009). A cTnI elevation was detected in 44.2% of the cases and was not associated with a significant increase in mortality (4.9 vs. 4.0%; OR: 1.2; 95% CI: 0.9-1.7; P=0.2). CONCLUSION: Post-procedural elevations of CK-MB, but not cTnI, influence 2-year mortality.
No takes yet. Share an insight, caveat, or question.
A 2005 study conducted a cohort in Patients undergoing percutaneous coronary intervention (PCI) (n=3,494). Post-procedural elevation of CK-MB vs. No CK-MB elevation was evaluated on 2-year mortality (OR 1.9, 95% CI 1.3-2.8, p=<0.001). Post-procedural elevation of CK-MB, but not troponin I, was associated with increased 2-year mortality after PCI.
Synapse has enriched 10 related papers. Consider them for comparative context: